Jushi Holdings (JUSHF) EBITDA Margin (2021 - 2026)

Jushi Holdings (JUSHF) reported EBITDA Margin of 2.38% for Q1 2026, up 531.0% year-over-year from 0.38% in Q1 2025, and up 108.24% quarter-over-quarter from 1.14% in Q4 2025.

Jushi Holdings (JUSHF) EBITDA Margin (2021 - 2026) Analysis & Trends

Jushi Holdings (JUSHF) has 6 years of EBITDA Margin data on file, last reported at 2.38% in Q1 2026.

  • EBITDA Margin for Q1 2026 came in at 2.38%, up 531.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 3.13% (up 1575.0% YoY), and the FY2025 annual result was 1.85%, up 2079.0% from the prior year.
  • EBITDA Margin advanced to 2.38% in Q1 2026 per JUSHF's latest filing, from 1.14% in the prior quarter.
  • Over five years, EBITDA Margin peaked at 16.58% in Q2 2022 and troughed at 182.16% in Q4 2022.
  • A 5-year average of 25.64% and a median of 18.93% in 2024 frame the typical range for EBITDA Margin.
  • The sharpest annual moves came in 2022 and 2023: EBITDA Margin tumbled 19579 bps in 2022, then surged 15559 bps in 2023.
  • A 5-year view of EBITDA Margin shows it stood at 182.16% in 2022, then soared by 85 bps to 26.57% in 2023, then rose by 29 bps to 18.93% in 2024, then surged by 106 bps to 1.14% in 2025, then surged by 108 bps to 2.38% in 2026.
  • Business Quant data shows JUSHF's EBITDA Margin at 2.38% in Q1 2026, 1.14% in Q4 2025, and 3.56% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 16.37%
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 36.83%
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 41.69%
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -1.01%
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 22.74%
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 22.39%
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -170.35%
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -16.25%
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 21.55%
10 Jushi Holdings - - 29.88 Mn 2.38%

Historic Data

Download Data
DateValue
Mar 31, 2026 2.38%
Dec 31, 2025 1.14%
Sep 30, 2025 3.56%
Jun 30, 2025 5.54%
Mar 31, 2025 -2.93%
Dec 31, 2024 -18.93%
Sep 30, 2024 -26.00%
Jun 30, 2024 -3.00%
Mar 31, 2024 -28.04%
Dec 31, 2023 -26.57%
Sep 30, 2023 -31.54%
Jun 30, 2023 -21.13%
Mar 31, 2023 -17.80%
Dec 31, 2022 -182.16%
Sep 30, 2022 -75.11%
Jun 30, 2022 16.58%
Mar 31, 2022 -31.92%
Dec 31, 2021 13.63%
Sep 30, 2021 73.63%
Jun 30, 2021 5.92%